GlaxoSmithKline company announced a voluntary recall of half million asthma inhalers in the U.S.


They explain that a level II recall means use of the device “may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.” As specified, he defect does not pose a danger to patients. The inhalers are being recalled from hospitals, pharmacies, retailers and wholesalers. The product which is subject of recall , manufactured at GSK’s Zebulon, North Carolina plant, .was distributed in a large area. Fortunately, customers complained only about a bulge in the inhaler wrapper that may indicate a leak of the propellant that administers the medicine.

GlaxoSmithKline plc (GSK) is a British pharmaceutical company headquartered in Brentford, London. It was established in 2000 and was the world’s sixth largest pharmaceutical company as of 2015, after Pfizer, Novartis, Merck, Hoffmann-La Roche and Sanofi.


Please enter your comment!
Please enter your name here